Cargando…
Complete Response to Eribulin in a Patient with Unresectable Liposarcoma: A Case Report and the Implications of New Biomarkers
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Japanese Society of Internal Medicine
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970819/ https://www.ncbi.nlm.nih.gov/pubmed/35831106 http://dx.doi.org/10.2169/internalmedicine.0379-22 |
| _version_ | 1784897976453300224 |
|---|---|
| author | Schöffski, Patrick |
| author_facet | Schöffski, Patrick |
| author_sort | Schöffski, Patrick |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9970819 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The Japanese Society of Internal Medicine |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99708192023-02-28 Complete Response to Eribulin in a Patient with Unresectable Liposarcoma: A Case Report and the Implications of New Biomarkers Schöffski, Patrick Intern Med Letters to the Editor The Japanese Society of Internal Medicine 2022-07-14 2023-02-01 /pmc/articles/PMC9970819/ /pubmed/35831106 http://dx.doi.org/10.2169/internalmedicine.0379-22 Text en Copyright © 2023 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Letters to the Editor Schöffski, Patrick Complete Response to Eribulin in a Patient with Unresectable Liposarcoma: A Case Report and the Implications of New Biomarkers |
| title | Complete Response to Eribulin in a Patient with Unresectable Liposarcoma: A Case Report and the Implications of New Biomarkers |
| title_full | Complete Response to Eribulin in a Patient with Unresectable Liposarcoma: A Case Report and the Implications of New Biomarkers |
| title_fullStr | Complete Response to Eribulin in a Patient with Unresectable Liposarcoma: A Case Report and the Implications of New Biomarkers |
| title_full_unstemmed | Complete Response to Eribulin in a Patient with Unresectable Liposarcoma: A Case Report and the Implications of New Biomarkers |
| title_short | Complete Response to Eribulin in a Patient with Unresectable Liposarcoma: A Case Report and the Implications of New Biomarkers |
| title_sort | complete response to eribulin in a patient with unresectable liposarcoma: a case report and the implications of new biomarkers |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970819/ https://www.ncbi.nlm.nih.gov/pubmed/35831106 http://dx.doi.org/10.2169/internalmedicine.0379-22 |
| work_keys_str_mv | AT schoffskipatrick completeresponsetoeribulininapatientwithunresectableliposarcomaacasereportandtheimplicationsofnewbiomarkers |